Endocrine Reviews

Papers
(The TQCC of Endocrine Reviews is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma418
Teprotumumab for the Treatment of Thyroid Eye Disease294
Anti-obesity pharmacotherapy for patients with genetic obesity due to defects in the leptin-melanocortin pathway252
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas228
Preclinical Rodent Models for Human Bone Disease, Including a Focus on Cortical Bone215
Historical aspects of testicular function: virility, androgen production and spermatogenesis186
The Changing Face of Turner Syndrome184
Papillary Craniopharyngioma: An Integrative and Comprehensive Review160
How Protein Methylation Regulates Steroid Receptor Function159
Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”156
New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature144
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology141
Phosphorylation-Dependent Regulation of Guanylyl Cyclase (GC)-A and Other Membrane GC Receptors128
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives108
Contemporary Biological Insights and Clinical Management of Craniopharyngioma107
Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics103
Risks of Iodine Excess84
Endocrine Manifestations and New Developments in Mitochondrial Disease80
The Weight of Place: Built Environment Correlates of Obesity and Diabetes75
Effects of Maternal Vitamin D Supplementation on Childhood Health74
Personalized Management of Pheochromocytoma and Paraganglioma71
The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty70
Time-restricted Eating for the Prevention and Management of Metabolic Diseases68
The Role of Iodine for Thyroid Function in Lactating Women and Infants68
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies68
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia67
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance64
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”62
Correction to: “Brown Adipose Tissue—A Translational Perspective”60
New Insights into the Structure and Function of Class B1 GPCRs58
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management56
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention55
Diabetes Mellitus, Energy Metabolism, and COVID-1953
The Spectrum of the Prader–Willi-like Pheno- and Genotype: A Review of the Literature51
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review51
Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma49
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases48
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction48
Insulin: A 100-Year-Old Discovery With a Fascinating History46
0.017565011978149